IKS Health sees massive growth in US healthcare. The company leverages technology, including AI, to deliver efficient solutions. It aims to expand its market share in the US. IKS Health is also eyeing potential expansion into the Australian and Canadian markets. The company plans to bring its expertise to India in the future.
Jio Platforms gets first Buy call! Nomura says ‘disruptor now the leader’; starts coverage with Rs 1,340 target
Shares of Jio Platforms listed at Rs 1,359 on BSE and NSE, a premium of 21% over the IPO price. Nomura set a target price